MCK Stock Price - McKesson Corp. Stock Quote (U.S.: NYSE) - MarketWatch

Open $143.70
Day Range 141.89 - 150.70
52 Week Range 133.82 - 178.86
Market Cap $29.48B
Shares Outstanding 206.34M
Public Float 205.83M
Beta 0.93
Rev. per Employee $2.63M
P/E Ratio 6.63
EPS $22.55
Yield 0.91%
Dividend $0.34
Ex-Dividend Date Feb 28, 2018
Short Interest 8.26M 03/29/18
% of Float Shorted 4.01%
Average Volume 1.78M

5 Day	4.64%
1 Month	5.67%
3 Month	-12.19%
YTD	-3.91%
1 Year	8.90%

MarketWatch
Other Dow Jones

McKesson's stock was up 0.9% just before CNBC report of Amazon shelving drug-selling plan

Apr. 16, 2018 at 1:15 p.m. ET
by Tomi Kilgore

McKesson's stock spikes up 4.6% after CNBC report of Amazon shelving drug selling plans

Apr. 16, 2018 at 1:11 p.m. ET
by Tomi Kilgore

Cigna’s $67 billion acquisition of Express Scripts will change the way drug prices get calculated

Mar. 10, 2018 at 8:25 a.m. ET
by Emma Court

How Amazon could lose its health-care bid while drug distributor stocks win

Feb. 16, 2018 at 3:30 p.m. ET
by Vitaliy Katsenelson

This might be the time when you can finally get quality stocks on sale

Feb. 15, 2018 at 7:02 a.m. ET
by Philip van Doorn

McKesson shares rise after Q3 profit, revenue beats; upbeat outlook

McKesson Corp. shares rose 0.7% in premarket trade Thursday after the company reported third-quarter profit and revenue beats and an upbeat 2018 outlook. Earnings for the latest quarter rose to $903 million, or $4.33 per share, from $633 million, or $2.85 per share in the year-earlier period. Adjusted earnings-per-share were $3.41, compared with the FactSet consensus of $2.95. The latest results exclude a $1.78 tax benefit due to corporate tax reform. Revenue rose to $53.62 billion from $50.13 billion, compared with the FactSet consensus of $51.98 billion. McKesson attributed its third-quarter results to a lower share count, growth across several business units, profits from acquisitions and a lower tax rate, including tax benefits unrelated to corporate tax reform. McKesson expects 2018 EPS of $7.65 to $9.00, compared with the FactSet consensus of $6.08, and 2018 adjusted EPS of $12.50 to $12.80, compared with the FactSet consensus of $12.26. Company shares have surged 20.9% over the last three months, compared with a 9.5% rise in the S&P 500 and a 11.6% rise in the Dow Jones Industrial Average .

Feb. 1, 2018 at 7:22 a.m. ET
by Emma Court

McKesson shares rise 0.7% pre-market

Feb. 1, 2018 at 7:12 a.m. ET
by Emma Court

McKesson expects 2018 adj. EPS of $12.50 to $12.80; FactSet consensus $12.26

Feb. 1, 2018 at 7:11 a.m. ET
by Emma Court

McKesson Q3 sales $53.6 bln vs. $50.1 bln; FactSet consensus $52 bln

Feb. 1, 2018 at 7:10 a.m. ET
by Emma Court

McKesson Q3 adj. EPS $3.41; FactSet consensus $2.95

Feb. 1, 2018 at 7:09 a.m. ET
by Emma Court

McKesson Q3 EPS $4.33 vs. $2.85

Feb. 1, 2018 at 7:07 a.m. ET
by Emma Court

Health care company shares drop sharply on entry by Amazon, Berkshire Hathaway and JPMorgan

Shares of companies across the health care industry, from health insurers to distributors, pharmacy-benefit managers and drugmakers, dropped in premarket trade on Tuesday after Amazon , Berkshire Hathaway and JPMorgan Chase announced plans for a new company to improve their employees' health care. The news hit pharmacy-benefit managers, pharmacy chains and drug distributors among the hardest, with CVS Health Corp. shares dropping 7.6%, Walgreens Boots Alliance shares dropping 5.7%, Express Scripts Holding Company dropping 4.8% and Cardinal Health Inc. shares dropping 4.3%. Several health insurers' shares also fell significantly, including UnitedHealth Group , which dropped 7.2%, Anthem Inc. , which dropped 7%, as well as Aetna Inc. and Humana Inc. . The moves reflect investor concerns that the Amazon, Berkshire Hathaway and JPMorgan initiative could shake up the status quo, especially given the three companies' large size and influential nature, and the potential interest of other employers in joining them. U.S. health care costs continue to rise year over year despite efforts to curb them, and many experts believe the fault lies with too-high prices. The SPDR S&P Biotech ETF declined 1% in premarket trade, as did the Health Care Select Sector SPDR . Shares of the ETFs have surged 15.5% and 12.3% respectively over the last three months, compared with a 10.9% increase in the S&P 500 and a 13.2% rise in the Dow Jones Industrial Average .

Jan. 30, 2018 at 7:37 a.m. ET
by Emma Court

Why hospital entry won’t hurt the generic drug business

Jan. 22, 2018 at 9:21 a.m. ET
by Emma Court

Got the flu? Investing in these companies may make you feel better

Jan. 22, 2018 at 9:20 a.m. ET
by Emma Court

Cardinal Health fires back at Amazon health-care threat: You can’t beat our prices

Jan. 9, 2018 at 9:30 p.m. ET
by Emma Court

Some companies have to wait for boost from lower tax rates

Jan. 9, 2018 at 2:28 p.m. ET
by Francine McKenna

McKesson CFO James Beer to leave to join Atlassian

Dec. 18, 2017 at 9:27 a.m. ET
by Tomi Kilgore

McKesson to appoint Britt Vitalone as CFO, effective Jan. 1

Dec. 18, 2017 at 9:16 a.m. ET
by Tomi Kilgore

McKesson CFO James Beer to leave company to pursue other opportunities

Dec. 18, 2017 at 9:15 a.m. ET
by Tomi Kilgore

There’s a surprisingly messy backstory to Amazon’s health care quest

Dec. 15, 2017 at 11:02 a.m. ET
by Emma Court

Justice Department Asks to Join Opioid Settlement Talks

The Justice Department is ramping up its efforts to curb the opioid epidemic, requesting to join settlement talks in sprawling litigation against the makers and distributors of prescription painkillers.

Apr. 3, 2018 at 2:19 p.m. ET
on The Wall Street Journal

Stocks to Watch: AmericsourceBergen, Walgreens, PepsiCo, Under Armour, Blue Apron, Amazon, GM

Among the companies with shares expected to trade actively in Tuesday's session are AmerisourceBergen, Walgreens Boots Alliance, PepsiCo, Under Armour and Blue Apron.

Feb. 13, 2018 at 9:26 a.m. ET
on The Wall Street Journal

New York City Sues Companies Over Opioid Abuse

New York City is following a wave of lawsuits against opioid manufacturers and distributors in accusing the companies of oversupplying the market and misrepresenting the safety of the drugs.

Jan. 23, 2018 at 2:16 p.m. ET
on The Wall Street Journal

The Opioid Crisis Has Plaintiff Lawyers Smelling Cash

Jan. 3, 2018 at 7:04 p.m. ET
on The Wall Street Journal

A Lesson From the Opioid Crisis

Dec. 22, 2017 at 10:59 p.m. ET
on Barron's

Cardinal Health Chief Executive George Barrett Stepping Down

Nov. 6, 2017 at 5:17 p.m. ET
on The Wall Street Journal

Listening to America’s Corporate Women

Oct. 10, 2017 at 12:02 a.m. ET
on The Wall Street Journal

States Push Ahead With Investigation Into Opioid Painkillers

Sep. 19, 2017 at 6:05 p.m. ET
on The Wall Street Journal

New Mexico Sues Drugmakers, Distributors Over Opioid Crisis

Sep. 7, 2017 at 6:40 p.m. ET
on The Wall Street Journal

Johnson & Johnson Wades Into Death Penalty Debate For First Time

Aug. 22, 2017 at 11:31 a.m. ET
on The Wall Street Journal

South Carolina Sues Purdue Pharma, Alleging Deceptive Opioid Marketing

Aug. 15, 2017 at 2:59 p.m. ET
on The Wall Street Journal

Falling U.S. Generic Drug Prices Hurt Manufacturers, Wholesalers

Aug. 4, 2017 at 6:14 p.m. ET
on The Wall Street Journal

Senator Expands Probe into Opioid Addiction Crisis

Jul. 27, 2017 at 9:33 a.m. ET
on The Wall Street Journal

McKesson Shareholders Reject Executive Compensation Packages

Jul. 26, 2017 at 5:11 p.m. ET
on The Wall Street Journal

AmerisourceBergen and AbbVie Top Barron’s 500

May. 22, 2017 at 1:45 p.m. ET
on Barron's

Strong Profits Help Stocks Rebound From D.C. Woes

May. 20, 2017 at 9:39 a.m. ET
on Barron's

Stocks to Watch: Deere, Campbell Soup, Foot Locker

May. 19, 2017 at 9:29 a.m. ET
on The Wall Street Journal

Delivery Startup Dropoff Inc. Scales Up for Businesses

May. 8, 2017 at 7:30 a.m. ET
on The Wall Street Journal

Arkansas Officials Prepare to Execute Ledell Lee After Court Ruling

Apr. 20, 2017 at 10:43 p.m. ET
on The Wall Street Journal

Cardinal Health Feels Pain of Falling Drug Prices

Apr. 18, 2017 at 11:56 a.m. ET
on The Wall Street Journal

Other News
Press Releases

CNBC: Amazon kills plan to sell drugs to hospitals

Apr. 16, 2018 at 1:16 p.m. ET
on Seeking Alpha

McKesson Is Undervalued

Apr. 16, 2018 at 1:59 a.m. ET
on Seeking Alpha

Top 10 Net Payout Yields - April 2018

Apr. 13, 2018 at 2:46 p.m. ET
on Seeking Alpha

Brunch, Craft Beer, And Investing: A Turning Point

Apr. 11, 2018 at 7:23 a.m. ET
on Seeking Alpha

Valuation Dashboard: Healthcare - Update

Apr. 4, 2018 at 5:07 p.m. ET
on Seeking Alpha

Justice Department Asks to Join Opioid Settlement Talks

Apr. 3, 2018 at 2:19 p.m. ET
on The Wall Street Journal

Distribution Network And Wide Moat - 4 Undervalued Picks

Apr. 3, 2018 at 10:34 a.m. ET
on Seeking Alpha

Venture Capital Deals Of The Week: Small Molecules And Software

Mar. 31, 2018 at 10:18 a.m. ET
on Seeking Alpha

Investors Are Left To Speculate On The Reasons For Rite Aid's Decision To Enter Into A Merger With A Binary Outcome

Mar. 29, 2018 at 11:47 a.m. ET
on Seeking Alpha

Merrill Lynch Says Buy These 8 Stocks for Q1 Earnings Surprises

Mar. 29, 2018 at 8:16 a.m. ET
on 247WallSt.com

Drug stocks in the red on as Trump mulls suing pharma firms over opioid crisis

Mar. 19, 2018 at 3:35 p.m. ET
on Seeking Alpha

Trump to release opioid epidemic plan

Mar. 19, 2018 at 4:25 a.m. ET
on Seeking Alpha

Finding Value: 5 Attractively Priced Stocks Uncovered By Our 3 Favorite Multiples

Mar. 16, 2018 at 2:53 a.m. ET
on Seeking Alpha

Valuation Dashboard: Healthcare - Update

Mar. 12, 2018 at 11:31 a.m. ET
on Seeking Alpha

Premarket analyst action - healthcare (continued)

Mar. 8, 2018 at 8:40 a.m. ET
on Seeking Alpha

Wall Street Breakfast: QE Hints Awaited From ECB

Mar. 8, 2018 at 6:59 a.m. ET
on Seeking Alpha

Opioid settlement talks hit roadblocks

Mar. 8, 2018 at 3:17 a.m. ET
on Seeking Alpha

Wall Street Breakfast: Markets Weighed Down By Cohn Exit

Mar. 7, 2018 at 6:59 a.m. ET
on Seeking Alpha

Behind Depomed’s Business Strategy

Mar. 7, 2018 at 6:19 a.m. ET
on MarketRealist.com

Opioid overdoses spiked 30% in a year

Mar. 7, 2018 at 3:53 a.m. ET
on Seeking Alpha

Global Healthcare Mobility Solutions Market Opportunities 2018: AT&T, CERNER CORPORATION, McKesson Corporation, SAP SE

Apr. 11, 2018 at 3:30 a.m. ET
on marketresearch.biz

McKesson Launches Health Mart Atlas

Apr. 9, 2018 at 10:00 a.m. ET
on BusinessWire - BZX

Laboratory Informatics Market Size, Share & Trends Analysis Report By Product, By Delivery Mode, By Component, By End-use And Segment Forecasts, 2018 - 2025

Apr. 3, 2018 at 10:02 a.m. ET
on PR Newswire - PRF

This Morning's Technical Outlook on Services Stocks -- Walgreens Boots Alliance, AmerisourceBergen, Cardinal Health, and McKesson

Apr. 3, 2018 at 6:55 a.m. ET
on PR Newswire - PRF

Global Wireless Electronic Records Market Opportunities 2018: eClinicalWorks, Allscripts Healthcare Solution, NextGen Healthcare

Apr. 3, 2018 at 5:08 a.m. ET
on marketresearch.biz

Global Healthcare Information Technology (IT) Market Opportunities 2018: McKesson Corporation, Epic Systems Corporation, Dell Technologies

Apr. 3, 2018 at 3:38 a.m. ET
on marketresearch.biz

United States : AcelRx announces appointment of John Saia as General Counsel

Mar. 28, 2018 at 7:09 p.m. ET
on Euclid Tenders Info

AcelRx announces appointment of John Saia as General Counsel

Mar. 27, 2018 at 7:00 a.m. ET
on PR Newswire - PRF

Clinical decision support systems market is projected to grow at a CAGR of 11.8%

Mar. 22, 2018 at 12:52 p.m. ET
on PR Newswire - PRF

Global vendor neutral archive market growth is expected to be driven by increasing need for systematic storage of patients' data

Mar. 22, 2018 at 3:50 a.m. ET
on marketresearch.biz

Global Hospital Information Systems (HIS) Industry

Mar. 20, 2018 at 2:31 p.m. ET
on PR Newswire - PRF

Global Telemental Health Market by 2024 – Leading Countries, Growth, Drivers, Risks, Opportunities, Forecast & Top Vendors Analysis

Mar. 20, 2018 at 8:13 a.m. ET
on Heraldkeeper

Global Film Dressing Market Opportunities 2018: Nipro, COVIDIEN, ConvaTec Inc, JXTG Holdings, Coloplast Group, McKesson Corporation

Mar. 20, 2018 at 2:57 a.m. ET
on marketresearch.biz

United States : Harry S. Truman Memorial Veterans Hospital Reduced Opioid PrescriptionsMcCaskill Applauds Efforts, Seeks Additional Details

Mar. 16, 2018 at 7:43 p.m. ET
on Euclid Tenders Info

Retail And Wholesale Global Market Report 2018

Mar. 15, 2018 at 1:32 p.m. ET
on PR Newswire - PRF

Europe Telehealth Market Industry Size, Share, Trends, Growth Analysis By Hardware, software, Services – Cerner Corporation, GE Healthcare, Honeywell Life Care Solutions, McKesson Corporation

Mar. 15, 2018 at 11:39 a.m. ET
on Heraldkeeper

Healthcare IT Outsourcing Market Share 2018 Industry Analysis, Growth, and Forecast to 2021

Mar. 5, 2018 at 1:03 p.m. ET
on Financeswire

Population Health Management Market Share 2018 Industry Analysis, Growth, and Forecast to 2022

Mar. 5, 2018 at 7:21 a.m. ET
on Financeswire

Revenue Cycle Management Market Share 2018 Industry Analysis, Growth, and Forecast to 2022

Mar. 5, 2018 at 7:03 a.m. ET
on Financeswire

United States : McKesson Specialty Health and Cryoport Collaborate to Bolster Logistics Services to Support Commercialization of Cell and Gene Therapies

Feb. 27, 2018 at 6:37 p.m. ET
on Euclid Tenders Info

McKesson Corp. is a health services and information technology company, which provides medicines, pharmaceutical and care management products. It operates through two segments: McKesson Distribution Solutions and McKesson Technology Solutions. The McKesson Distribution Solutions segment distributes ethical and proprietary drugs, medical-surgical supplies and equipment and health and beauty care products throughout North America. It also provides specialty pharmaceutical solutions for biotech and pharmaceutical manufacturers, sells financial, operational and clinical solutions for pharmacies. The McKesson Technology Solutions segment provides software, automation, business services and consulting to hospitals, physician offices, imaging centers and home healthcare. It also provides interactive connectivity services that streamline clinical, financial and administrative communication between patients, providers, payers, pharmacies and financial institutions agencies and payers. The company was founded by John McKesson and Charles Olcott in 1833 and is headquartered in Wilmington, DE. (See Full Profile)

Sell
Under
Hold
Over
Buy

Number of Ratings 20 Full Ratings

Benzinga's Top Upgrades, Downgrades For March 8, 2018

Mar. 8, 2018 at 9:13 a.m. ET
on Benzinga.com

Benzinga's Top Upgrades, Downgrades For January 24, 2018

Jan. 24, 2018 at 9:28 a.m. ET
on Benzinga.com

Benzinga's Top Upgrades, Downgrades For December 4, 2017

Dec. 4, 2017 at 9:16 a.m. ET
on Benzinga.com

Name	Chg %	Market Cap
Henry Schein Inc.	2.35%	$10.64B
Cerner Corp.	1.92%	$18.88B
Quality Systems Inc.	2.79%	$846.12M
Allscripts Healthcare Solutions Inc.	2.16%	$2.14B
Computer Programs & Systems Inc.	1.37%	$409.9M

Competitor Data Provided By

Dow	24,655.10	294.96	1.21%
S&P 500	2,684.48	28.18	1.06%
Nasdaq	7,171.52	64.87	0.91%
GlobalDow	3,073.97	15.99	0.52%
Gold	1,350.60	2.70	0.20%
Oil	66.52	-0.87	-1.29%

McKesson Corp.

$ 149.85

Customize MarketWatch

No Items in Watchlist

No Saved Watchlists

Uh oh

No Recent Tickers

McKesson's stock was up 0.9% just before CNBC report of Amazon shelving drug-selling plan

McKesson's stock spikes up 4.6% after CNBC report of Amazon shelving drug selling plans

McKesson shares rise 0.7% pre-market

McKesson expects 2018 adj. EPS of $12.50 to $12.80; FactSet consensus $12.26

McKesson Q3 sales $53.6 bln vs. $50.1 bln; FactSet consensus $52 bln

McKesson Q3 adj. EPS $3.41; FactSet consensus $2.95

McKesson Q3 EPS $4.33 vs. $2.85

McKesson to appoint Britt Vitalone as CFO, effective Jan. 1

McKesson CFO James Beer to leave company to pursue other opportunities

Stocks

Columns

Authors

Topics

^$ 149.85